pharma news

News

Jazz secures FDA approval for Ziihera in first-line HER2-pos...

Jazz Pharmaceuticals has been granted US approval for two combinations of its cancer drug Ziihera HER2+ advanced GEA.

News

Entropy, UCSF Pre-CTA for Ph2 psilocin vs Lexapro in MDD

Entropy signs Pre-CTA with UCSF to develop a US-based Phase 2 trial comparing IV psilocin treatment directly against escitalopram (Lexapro) in MDD.

News

The puzzle of Alzheimer's, HCP hand holds digital graphic of brain and missing puzzle piece

Neurocrine receives FDA IND Acceptance for Alzheimer’s Ph2

Nxera Pharma has announced that partner Neurocrine Biosciences has received IND Acceptance from the FDA a Ph2 of NBI-1117567 in Alzheimer's cognition.

News

Expanded US Imaavy approval first ever for wAIHA

The FDA has approved Johnson & Johnson's Imaavy (nipocalimab-aahu) for the treatment of warm autoimmune haemolytic anaemia (wAIHA).

News

Final judgement favours TwinStrand in Guardant patent case

Court issues final judgement in favour of TwinStrand and the University of Washington in their patent infringement suit against Guardant Health.

News

Trodelvy gets EU nod for first-line triple-neg breast cancer

A new EC authorisation expands Gilead's market for triple-negative breast cancer ADC Trodelvy.

Jazz secures FDA approval for Ziihera in first-line HER2-pos...

Entropy, UCSF Pre-CTA for Ph2 psilocin vs Lexapro in MDD

Neurocrine receives FDA IND Acceptance for Alzheimer’s Ph2

Expanded US Imaavy approval first ever for wAIHA

Final judgement favours TwinStrand in Guardant patent case

Trodelvy gets EU nod for first-line triple-neg breast cancer

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks